Belite Bio (BLTE) Accumulated Depreciation & Amortization (2021 - 2025)
Belite Bio's quarterly Accumulated Depreciation & Amortization came in at $192000.0 in Q4 2025, up 540.0% year-on-year from $30000.0 in Q4 2024, and up 540.0% quarter-over-quarter from $30000.0 in Q4 2024.
Belite Bio has reported Accumulated Depreciation & Amortization for 5 years, with the latest figure at $192000.0 in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 540.0% year-over-year to $192000.0; the trailing twelve-month figure through Dec 2025 stood at $192000.0 (up 540.0% YoY), and the FY2025 full-year result was $192000.0, up 540.0% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2025 stood at $192000.0, up from $30000.0 in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $192000.0 in Q4 2025, with the low at -$487000.0 in Q4 2022.
- Average Accumulated Depreciation & Amortization over 5 years is -$128800.0, with a median of $30000.0 recorded in 2024.
- Year-over-year, Accumulated Depreciation & Amortization sank 1136.17% in 2022 and surged 540.0% in 2025.
- Tracing BLTE's Accumulated Depreciation & Amortization over 5 years: stood at $47000.0 in 2021, then slumped by 1136.17% to -$487000.0 in 2022, then advanced by 12.53% to -$426000.0 in 2023, then surged by 107.04% to $30000.0 in 2024, then surged by 540.0% to $192000.0 in 2025.
- The last three Accumulated Depreciation & Amortization figures came in at $192000.0 (Q4 2025), $30000.0 (Q4 2024), and -$426000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Belite Bio | 4.92 Bn | 4.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 192,000.00 |
| Dec 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Dec 31, 2023 | -426,000.00 |
| Dec 31, 2023 | -426,000.00 |
| Dec 31, 2022 | -487,000.00 |
| Dec 31, 2022 | -487,000.00 |
| Dec 31, 2021 | 47,000.00 |
| Dec 31, 2021 | 47,000.00 |